{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T04:03:34Z","timestamp":1792728214322,"version":"4.5.0"},"reference-count":31,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,9,13]],"date-time":"2024-09-13T00:00:00Z","timestamp":1726185600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["JACC: Advances"],"published-print":{"date-parts":[[2024,11]]},"DOI":"10.1016\/j.jacadv.2024.101331","type":"journal-article","created":{"date-parts":[[2024,10,14]],"date-time":"2024-10-14T03:38:33Z","timestamp":1728877113000},"page":"101331","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"title":["Consequences of Recurrent Hyperkalemia on Cardiovascular Outcomes and Mortality"],"prefix":"10.1016","volume":"3","author":[{"given":"George","family":"Bakris","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abiy","family":"Agiro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fan","family":"Mu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erin E.","family":"Cook","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8576-8614","authenticated-orcid":false,"given":"Alexandra","family":"Greatsinger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manasvi","family":"Sundar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5745-5677","authenticated-orcid":false,"given":"Helen","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elaine","family":"Louden","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ellen","family":"Colman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pooja","family":"Desai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"13","key":"10.1016\/j.jacadv.2024.101331_bib1","doi-asserted-by":"crossref","first-page":"1467","DOI":"10.1007\/s40265-021-01555-5","article-title":"Hyperkalemia in chronic kidney disease in the new era of kidney protection therapies","volume":"81","author":"Valdivielso","year":"2021","journal-title":"Drugs"},{"issue":"6","key":"10.1016\/j.jacadv.2024.101331_bib2","first-page":"487","article-title":"Potassium disorders: hypokalemia and hyperkalemia","volume":"92","author":"Viera","year":"2015","journal-title":"Am Fam Physician"},{"issue":"Suppl 3","key":"10.1016\/j.jacadv.2024.101331_bib3","doi-asserted-by":"crossref","first-page":"iii2","DOI":"10.1093\/ndt\/gfz206","article-title":"Hyperkalemia: pathophysiology, risk factors and consequences","volume":"34","author":"Hunter","year":"2019","journal-title":"Nephrol Dial Transplant"},{"issue":"6","key":"10.1016\/j.jacadv.2024.101331_bib4","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1080\/03007995.2018.1433141","article-title":"The prevalence of hyperkalemia in the United States","volume":"34","author":"Betts","year":"2018","journal-title":"Curr Med Res Opin"},{"issue":"6","key":"10.1016\/j.jacadv.2024.101331_bib5","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0218739","article-title":"Predictors for repeated hyperkalemia and potassium trajectories in high-risk patients - a population-based cohort study","volume":"14","author":"Adelborg","year":"2019","journal-title":"PLoS One"},{"issue":"Suppl_1","key":"10.1016\/j.jacadv.2024.101331_bib6","doi-asserted-by":"crossref","DOI":"10.1161\/circ.148.suppl_1.11709","article-title":"High rates of hyperkalemia recurrence after medical nutrition therapy in patients with heart failure: REVOLUTIONIZE I real-world evidence study","volume":"148","author":"Agiro","year":"2023","journal-title":"Circulation"},{"issue":"11","key":"10.1016\/j.jacadv.2024.101331_bib7","article-title":"Elevated potassium levels in patients with congestive heart failure: occurrence, risk factors, and clinical outcomes: a Danish population-based cohort study","volume":"7","author":"Thomsen","year":"2018","journal-title":"J\u00a0Am Heart Assoc"},{"issue":"3","key":"10.1016\/j.jacadv.2024.101331_bib8","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1093\/ehjcvp\/pvy015","volume":"4","author":"Rosano","year":"2018","journal-title":"Eur Heart J Cardiovasc Pharmacother"},{"key":"10.1016\/j.jacadv.2024.101331_bib9","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.ijcard.2017.07.035","article-title":"Incidence and determinants of hyperkalemia and hypokalemia in a large healthcare system","volume":"245","author":"Nilsson","year":"2017","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.jacadv.2024.101331_bib10","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2021.105835","article-title":"Hyperkalemia with RAAS inhibition: mechanism, clinical significance, and management","volume":"172","author":"Hundemer","year":"2021","journal-title":"Pharmacol Res"},{"key":"10.1016\/j.jacadv.2024.101331_bib11","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2023.1101068","article-title":"Renin-angiotensin-aldosterone pathway modulators in chronic kidney disease: a comparative review","volume":"14","author":"Alshahrani","year":"2023","journal-title":"Front Pharmacol"},{"issue":"5","key":"10.1016\/j.jacadv.2024.101331_bib12","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1016\/j.ekir.2021.02.038","article-title":"Hyperkalemia and its association with mortality, cardiovascular events, hospitalizations, and intensive care unit admissions in a population-based retrospective cohort","volume":"6","author":"Hougen","year":"2021","journal-title":"Kidney Int Rep"},{"issue":"2","key":"10.1016\/j.jacadv.2024.101331_bib13","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/j.mayocpiqo.2020.10.001","article-title":"Cardiovascular and renal outcomes associated with hyperkalemia in chronic kidney disease: ahospital-based cohort study","volume":"5","author":"Kohsaka","year":"2021","journal-title":"Mayo Clin Proc Innov Qual Outcomes"},{"issue":"3","key":"10.1016\/j.jacadv.2024.101331_bib14","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1159\/000479802","article-title":"Association of serum potassium with all-cause mortality in patients with and without heart failure, chronic kidney disease, and\/or diabetes","volume":"46","author":"Collins","year":"2017","journal-title":"Am J Nephrol"},{"issue":"1","key":"10.1016\/j.jacadv.2024.101331_bib15","doi-asserted-by":"crossref","DOI":"10.1111\/ijcp.13421","article-title":"Associations between serum potassium and adverse clinical outcomes: a systematic literature review","volume":"74","author":"Palaka","year":"2020","journal-title":"Int J Clin Pract"},{"issue":"17","key":"10.1016\/j.jacadv.2024.101331_bib16","doi-asserted-by":"crossref","first-page":"1535","DOI":"10.1093\/eurheartj\/ehy100","article-title":"Serum potassium and adverse outcomes across the range of kidney function: a CKD Prognosis Consortium meta-analysis","volume":"39","author":"Kovesdy","year":"2018","journal-title":"Eur Heart J"},{"issue":"1","key":"10.1016\/j.jacadv.2024.101331_bib17","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1186\/s12882-018-1007-1","article-title":"Serum potassium as a predictor of adverse clinical outcomes in patients with chronic kidney disease: new risk equations using the UK clinical practice research datalink","volume":"19","author":"Furuland","year":"2018","journal-title":"BMC Nephrol"},{"issue":"9","key":"10.1016\/j.jacadv.2024.101331_bib18","doi-asserted-by":"crossref","first-page":"1610","DOI":"10.1093\/ndt\/gfx312","article-title":"Elevated potassium levels in patients with chronic kidney disease: occurrence, risk factors and clinical outcomes-a Danish population-based cohort study","volume":"33","author":"Thomsen","year":"2018","journal-title":"Nephrol Dial Transplant"},{"issue":"5","key":"10.1016\/j.jacadv.2024.101331_bib19","doi-asserted-by":"crossref","first-page":"762","DOI":"10.2215\/CJN.05850809","article-title":"Serum potassium and outcomes in CKD: insights from the RRI-CKD cohort study","volume":"5","author":"Korgaonkar","year":"2010","journal-title":"Clin J Am Soc Nephrol"},{"issue":"5","key":"10.1016\/j.jacadv.2024.101331_bib20","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1053\/j.ajkd.2015.10.011","article-title":"Renin-angiotensin system inhibitors and kidney and cardiovascular outcomes in patients with CKD: abayesian network meta-analysis of randomized clinical trials","volume":"67","author":"Xie","year":"2016","journal-title":"Am J Kidney Dis"},{"issue":"1","key":"10.1016\/j.jacadv.2024.101331_bib21","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1093\/ckj\/sfab159","article-title":"Patterns of chronic and transient hyperkalaemia and clinically important outcomes in patients with chronic kidney disease","volume":"15","author":"Trevisan","year":"2022","journal-title":"Clin Kidney J"},{"issue":"4","key":"10.1016\/j.jacadv.2024.101331_bib22","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1097\/EDE.0b013e3181a663cc","article-title":"High-dimensional propensity score adjustment in studies of treatment effects using health care claims data","volume":"20","author":"Schneeweiss","year":"2009","journal-title":"Epidemiology"},{"issue":"1","key":"10.1016\/j.jacadv.2024.101331_bib23","doi-asserted-by":"crossref","first-page":"90","DOI":"10.2215\/CJN.01730215","article-title":"Association between serum potassium and outcomes in patients with reduced kidney function","volume":"11","author":"Luo","year":"2016","journal-title":"Clin J Am Soc Nephrol"},{"issue":"2","key":"10.1016\/j.jacadv.2024.101331_bib24","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1159\/000446268","article-title":"Potassium: from physiology to clinical implications","volume":"2","author":"Zacchia","year":"2016","journal-title":"Kidney Dis"},{"issue":"6","key":"10.1016\/j.jacadv.2024.101331_bib25","doi-asserted-by":"crossref","DOI":"10.3390\/ijms24065370","article-title":"The effect of aldosterone on cardiorenal and metabolic systems","volume":"24","author":"Otsuka","year":"2023","journal-title":"Int J Mol Sci"},{"issue":"1","key":"10.1016\/j.jacadv.2024.101331_bib26","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/S2213-8587(17)30367-4","article-title":"Cardiometabolic outcomes and mortality in medically treated primary aldosteronism: a retrospective cohort study","volume":"6","author":"Hundemer","year":"2018","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"38","key":"10.1016\/j.jacadv.2024.101331_bib27","doi-asserted-by":"crossref","first-page":"3781","DOI":"10.1093\/eurheartj\/ehac352","article-title":"Aldosterone in chronic kidney disease and renal outcomes","volume":"43","author":"Verma","year":"2022","journal-title":"Eur Heart J"},{"issue":"22","key":"10.1016\/j.jacadv.2024.101331_bib28","doi-asserted-by":"crossref","first-page":"2836","DOI":"10.1016\/j.jacc.2020.04.021","article-title":"Abnormalities of potassium in heart failure: JACC state-of-the-art review","volume":"75","author":"Ferreira","year":"2020","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"11 Suppl","key":"10.1016\/j.jacadv.2024.101331_bib29","first-page":"S212","article-title":"Evaluation of the treatment gap between clinical guidelines and the utilization of renin-angiotensin-aldosterone system inhibitors","volume":"21","author":"Epstein","year":"2015","journal-title":"Am J Manag Care"},{"issue":"3","key":"10.1016\/j.jacadv.2024.101331_bib30","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0213192","article-title":"Hyperkalemia and renin-angiotensin aldosterone system inhibitor therapy in chronic kidney disease: a general practice-based, observational study","volume":"14","author":"Jun","year":"2019","journal-title":"PLoS One"},{"issue":"7-8","key":"10.1016\/j.jacadv.2024.101331_bib31","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1159\/000531102","article-title":"Discontinuation of renin-angiotensin-aldosterone system inhibitors secondary to hyperkalemia translates into higher cardiorenal outcomes","volume":"54","author":"An","year":"2023","journal-title":"Am J Nephrol"}],"container-title":["JACC: Advances"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2772963X24006112?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2772963X24006112?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,1,20]],"date-time":"2025-01-20T22:17:40Z","timestamp":1737411460000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2772963X24006112"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11]]},"references-count":31,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2024,11]]}},"alternative-id":["S2772963X24006112"],"URL":"https:\/\/doi.org\/10.1016\/j.jacadv.2024.101331","relation":{},"ISSN":["2772-963X"],"issn-type":[{"value":"2772-963X","type":"print"}],"subject":[],"published":{"date-parts":[[2024,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Consequences of Recurrent Hyperkalemia on Cardiovascular Outcomes and Mortality","name":"articletitle","label":"Article Title"},{"value":"JACC: Advances","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jacadv.2024.101331","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier on behalf of the American College of Cardiology Foundation.","name":"copyright","label":"Copyright"}],"article-number":"101331"}}